Autoimmune Diseases  >>  Eticovo (etanercept-ykro)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Eticovo (etanercept-ykro) / Biogen, Organon, Samsung, Ewopharma, Yuhan Corp, Mundipharma, Bionovis
NCT01895309 / 2012-005026-30: A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy

Checkmark RA
Jul 2015 - Jul 2015: RA
Completed
3
596
Europe
Enbrel (etanercept), SB4 (proposed biosimilar to etanercept)
Samsung Bioepis Co., Ltd.
Rheumatoid Arthritis
04/14
10/15

Download Options